BB Biotech
Swiss company
ISIN CH0038389992 LEI 391200MBZQNPFHIVKO34
Follow BB Biotech
Weekly email: filings, results
Net income
−CHF 357.8M
+11.6% vs prior year
EPS, diluted
−CHF 6.50
+11.1% vs prior year
Operating cash flow
CHF 231.1M
+343.8% vs prior year
Source: ESEF annual reports · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY22 | −CHF 357.8M |
| FY21 | −CHF 404.8M |
| FY20 | CHF 691.2M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY22 | CHF 212.2M | CHF 27.3M |
| FY21 | CHF 199.4M | CHF 9.5M |
| FY20 | CHF 188.4M | CHF 8.3M |